$ACHN News 6 stocks to watch 2:35 p.m. Oct. 29, 2014 -

New Post Public Reply Private Reply Replies (0) Message Board

Oct 31, 2014 at 1:00 PM

$ACHN News

6 stocks to watch 2:35 p.m. Oct. 29, 2014 - The Trading Deck
6 stocks to watch 3:10 p.m. Oct. 22, 2014 - The Trading Deck
6 stocks to watch 3:36 p.m. Oct. 9, 2014 - The Trading Deck
10 Nasdaq stocks with returns of at least 240% in 2014 5:38 p.m. Sept. 11, 2014 - Philip van Doorn
5 stocks to watch 1:38 p.m. Sept. 3, 2014 - The Trading Deck
Six stocks to watch 1:47 p.m. Aug. 27, 2014 - The Trading Deck
S&P 500 reaches firmer technical ground 11:30 a.m. Aug. 18, 2014 - Michael Ashbaugh
Stocks trim Ukraine-inspired fall, post weekly gain 4:08 p.m. Aug. 15, 2014 - Anora Mahmudova
In focus: New highs premature? 9:03 p.m. June 18, 2014 - Lawrence G. McMillan
Achillion shares up; FDA lifts hold on hepatitis C drug 10:25 a.m. June 10, 2014 - Anna Prior
U.S. stock futures sink on shutdown fears 8:38 a.m. Sept. 30, 2013 - Barbara Kollmeyer
Zynga shares rise, Achillion drops after hours 5:51 p.m. July 1, 2013 - Wallace Witkowski
FDA puts Achillion Hep C drug on clinical hold 5:16 p.m. July 1, 2013 - MarketWatch.com
Five stocks making moves 3:12 p.m. Feb. 14, 2013 - The Trading Deck
Thursday’s top gaining & declining stocks 5:02 p.m. Sept. 27, 2012 - Greg Morcroft
Achillion sees progress in hepatitis C study 9:04 a.m. Sept. 27, 2012 - MarketWatch.com
Vertex to advance testing of oral HCV drug regimen 10:34 a.m. Sept. 25, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:37 p.m. Sept. 19, 2012 - MarketWatch
Achillion, Idenix move on price target changes 10:29 a.m. Sept. 19, 2012 - Val Brickates Kennedy
Gilead boosted as analysts hike price targets 10:42 a.m. Sept. 17, 2012 - Val Brickates Kennedy

Biggest Movers in Healthcare Stocks Now – TRNX MDCO ACHN AMGN 7:30 a.m. Oct. 28, 2014 - InvestorPlace.com
Speculating on Achillion's Boom-or-Bust Hep C Drug Study Results 8:39 a.m. Oct. 22, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – AMGN GILD REGN ACHN 2:00 p.m. Oct. 21, 2014 - InvestorPlace.com
Must See Charts: 4 Biotech Stocks to Watch in a Market Snapback 1:50 p.m. Oct. 17, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – REGN ACHN CBPO HZNP 8:45 a.m. Oct. 17, 2014 - InvestorPlace.com
Achillion Pharmaceuticals, Inc. Shares Trading At Highs Following Positive Comments From FBR Capital 1:28 p.m. Oct. 8, 2014 - benzinga.com
Top 5 Biotech Stocks Over The Past Year 1:28 p.m. Oct. 6, 2014 - benzinga.com
Insider Selling Jumps as Market Volatility Highest Since Summer 8:23 a.m. Oct. 4, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – ACHN THRX AGN VRTX 1:30 p.m. Oct. 3, 2014 - InvestorPlace.com
Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma 9:41 a.m. Oct. 3, 2014 - TheStreet.com
Achillion: Positioned To Deliver The Last Clinical Stage Nuc To The Highest Bidder 2:48 p.m. Oct. 2, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 10/1/14: SNTA, AGCO, RSG, DWA 8:28 a.m. Oct. 2, 2014 - Seeking Alpha
Achillion Pharmaceuticals, Inc. Less Attractive Amid Johnson & Johnson/Alios BioPharma Deal 11:19 a.m. Sept. 30, 2014 - benzinga.com
J&J Buying Alios, Going Up Against Gilead 11:02 a.m. Sept. 30, 2014 - Investors Business Daily
Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax 9:49 a.m. Sept. 30, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up 9/26/14: CONN, AEO, OPK, RSG 9:20 a.m. Sept. 29, 2014 - Seeking Alpha
Following Biotech Stocks After Price Declines Of Greater Than 50% 4:03 p.m. Sept. 25, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 9/23/14: Apple, Ulta, Intersections, Republic Services 10:42 a.m. Sept. 24, 2014 - Seeking Alpha
If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits 8:00 a.m. Sept. 16, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ACHN BLUE LCI SLXP 7:30 a.m. Sept. 16, 2014 - InvestorPlace.com

Critical Alerts For NetSuite, CVS Caremark, Netflix, VeriFone Systems and Achillion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 27, 2014 - PR Newswire - PRF
Achillion to Present Updated Clinical HCV Data on ACH-3102 and Preclinical Profile of ACH-3422 at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting 10:24 a.m. Oct. 8, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Dreamworks Animation, SunEdison, El Pollo Loco and Whole Foods Market Released By InvestorsObserver 9:31 a.m. Sept. 30, 2014 - PR Newswire - PRF
Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma 9:05 a.m. Sept. 16, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, LightInTheBox, VoxelJet, Whole Foods Market and Disney Released By InvestorsObserver 9:31 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Updates, Operational Milestones, Product Upgrades, and Energy Saving Programs - Research Reports on Achillion, DE, Honeywell, Lockheed Martin and L-3 Communications 8:35 a.m. Sept. 9, 2014 - PR Newswire - PRF
Global Hepatitis C Market 2014-2018 9:58 p.m. Sept. 8, 2014 - PR Newswire - PRF
Reveal Insider Trading for Facebook, Plug Power, Achillion Pharmaceuticals, Apple, Twitter, and Intel 8:55 a.m. Sept. 2, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, Intel, YY, JA Solar and Skullcandy Released By InvestorsObserver 9:31 a.m. Aug. 26, 2014 - PR Newswire - PRF
Biotechnology Stocks to Keep an Eye On 9:02 a.m. Aug. 20, 2014 - ACCESSWIRE
New Drug Launches, Technical Updates, New Facility, Clinical Trials Data, and Dividend Declarations - Research Reports on Covidien, Mylan, Baxter, Achillion and Perrigo 8:40 a.m. Aug. 20, 2014 - PR Newswire - PRF
Achillion Granted U.S. Patent for ACH-3102 and Structurally Related NS5A Inhibitors 4:06 p.m. Aug. 19, 2014 - GlobeNewswire
Achillion Achieves 100 Percent Sustained Virologic Response Rate (SVR4) From an Eight Week Phase 2 Trial Evaluating a Ribavirin-Free Regimen of ACH-3102 and Sofosbuvir for Genotype 1 HCV ("Proxy Study"

7:00 a.m. Aug. 15, 2014 - GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 8:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Achillion Reports Second Quarter and Six Month 2014 Financial Results 4:06 p.m. Aug. 7, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Synergy Resources, Invensense, JinkoSolar, and Harley-Davidson Released By InvestorsObserver 9:31 a.m. Aug. 5, 2014 - PR Newswire - PRF
Critical Alerts For Exelixis, Rocket Fuel, Netflix, Johnson & Johnson, and Achillion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 15, 2014 - PR Newswire - PRF
Technical Data on Health Care Sector Equities -- Research on Achillion Pharma, Novavax, Dendreon, and Exelixis 7:00 a.m. July 10, 2014 - PR Newswire - PRF
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion 5:50 a.m. July 7, 2014 - PR Newswire - PRF
Achillion Pharmaceuticals Added to the Russell 2000 and Russell Microcap Indexes 4:06 p.m. July 1, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

$4 Million Raised at Miracles for Kids Gala 2026

Anthony Geisler's Impactful Philanthropy Ever heard that old chestnut about putting your money where your mouth is? Well, Anthony Geisler, the chap behind Sequel Brands, sure seems to embody it. At the 2026 Miracles for Kids Night of Miracles Gala, he managed to corral over $4 million for families with critically ill kids. That's no chump change, let me tell you. The...

Frontera Energy's Q3 Results Call: Key Insights Ahead

What to Expect from Frontera’s Upcoming Call Frontera Energy’s got a date with the earnings table, and it’s set for November 11. The story here is about anticipation, folks. This Canadian energy player will lay its third-quarter results bare soon as trading wraps up. They’ll be breaking the nitty-gritty down in a call with the analysts that follows the next day,...

Cork's Market Power Surges in U.S. Wine Industry

Cork: The Unsung Hero of the Wine Bottle You'd think a simple piece of bark couldn't shift the billion-dollar wine industry, but cork closures are doing just that. According to new NielsenIQ data, these natural stoppers are holding their ground as top dogs in the U.S. wine market. Who would've guessed that cork would drive the highest off-premise revenue? That's some...

Sale Shifts Gregg Young Chevrolet to New Owners

Dealership Transition: A New Chapter in Marshalltown Get this—Gregg Young Chevrolet in Marshalltown, Iowa, is changing hands. This isn't some overnight affair; we're talking about a dealership that's been around and has history in the state. The keys are being passed from the Gregg Young Automotive Group to Alan Reuber and Matthew Barrows, under the stewardship of North...

Air Force Officer's Pretrial Solitary Challenged

High Stakes at Joint Base Anacostia-Bolling Let's get real, the courtroom showdown set for November 17 over at Joint Base Anacostia-Bolling isn’t just another blip on the radar. We're talking about Major Jason P. Watson, a seasoned Air Force officer with an unblemished track record and more tours than most folks care to count. Monument Legal is at his side, hammering at...

InsCorp's Steady Q3 Climb Mirrors Strategic Focus

Riding the Revenue Wave Now we're talking about a bank knowing their business—InsCorp, Inc. recently flaunted a 12% year-on-year revenue bump for 3Q26, a testament to a strategy that's clearly sticking. Still, while those numbers are nice and shiny, the detailed breakdown shows earnings per share (EPS) barely budged from last quarter, coming in at $0.73, just a hair...

Why Haunted Attractions Keep Us Coming Back for Fear

Welcome to Fear Incarnated Ah, Kansas City. More than just jazz and barbeque. You’ve got these infamous haunted houses that turn every horror flick into a mere Saturday morning cartoon. Enter Edge of Hell and Beast Haunted Attraction. Two horrifying museums of fear that somehow lure us like flies to sugar from miles away. What's the secret sauce? Well, that’s half the...

Mazu Culture Forum Unveils New Initiatives in China

A Cultural Tapestry Unfurls in Putian Picture this: a kaleidoscope of cultures and ideas unraveling in the coastal city of Putian. The 11th Global Mazu Culture Forum kicks off on October 31, bringing together minds—both fresh and seasoned—from an impressive array of 47 countries and regions. It's more than a forum; it's a vibrant crossroads of innovation, tradition,...

Vuzix to Reveal Q3 2026 Results in Upcoming Call

Vuzix Sets the Stage for Its Q3 2026 Earnings Call Out of all the snazzy tech plays you scribble down on a placemat over morning coffee, Vuzix Corporation (NASDAQ: VUZI) is gearing up for some spotlight action. This November 12, at 4:30 PM Eastern Time, they’re unveiling their third quarter 2026 earnings results, piping hot through a conference call. It's the kind of...

FirstService Unveils New LA Luxury Living Insights

Fresh Insights from Los Angeles' Vertical Living Scene FirstService Residential is throwing the spotlight on luxury high-rises in Los Angeles with their latest episode of Skyline Sessions. Catching wind of this release feels like getting the inside scoop from the horse's mouth—it's about the finer points shaping posh city living in a bustling Californian metropolis....